Low-Dose Rivaroxaban Fails to Lower Cardiovascular Events in Advanced CKD While Increasing Major Bleeding Risks in Patients.
by Badve SV, Perkovic V (...) Gallagher M et 34 al. in JAMA #MedSky
š get more here
š read the article: https://jamanetwork.com/journals/jama/fullarticle/2850100